Eurycoma longifolia Jack — known throughout Southeast Asia as Tongkat Ali — is a flowering tree of the family Simaroubaceae, native to Malaysia, Indonesia, Vietnam, Cambodia, Myanmar, Laos, and Thailand. It is one of the most thoroughly documented traditional herbal medicines in the region, used for centuries across multiple cultures for a remarkably broad spectrum of conditions. This page summarizes the ethnobotany, phytochemistry, pharmacological effects, and safety profile of the plant as established by peer-reviewed research.
I. Botanical Identity and Regional Names
The plant is a tall, slender, shrubby tree that grows in sandy soils. Its compound leaves can reach up to 1 m in length, with lanceolate to ovate-lanceolate leaflets. Flowers are small and reddish; the drupes are ovoid, turning dark reddish-brown when ripe. Genetic diversity is declining due to widespread harvesting, and commercial cultivation in Malaysia is increasingly used to conserve wild populations.
| Country / Region | Local Name | Meaning / Notes |
|---|---|---|
| Malaysia | Tongkat Ali / Malaysian Ginseng | "Ali's walking stick" — reference to aphrodisiac property |
| Indonesia | Pasak Bumi / Bedara Pahit | "Earth peg"; "bitter jujube" |
| Thailand | Ian-don | — |
| Vietnam | Cay ba benh | "Three-disease plant" |
| Laos | Tho nan | — |
II. Traditional Uses by Plant Part
Different parts of the plant carry distinct ethnomedicinal applications across Southeast Asian communities. The roots — particularly the taproots and root bark — are the most commercially significant and most extensively studied.
| Plant Part | Traditional Application | Preparation Method |
|---|---|---|
| Taproots / Root extract | Sexual dysfunction, aphrodisiac, malaria, cancer, diabetes, anxiety, aches, osteoporosis, leukemia, energy, strength, syphilis | Water decoction; capsule; tonic |
| Root bark | Diarrhea, fever | Decoction |
| Taproots (whole) | High blood pressure | Decoction |
| Bark (stem) | Vermifuge (intestinal worms) | Oral preparation |
| Leaves | Skin itches | Topical wash decoction |
| Fruits | Dysentery | Oral preparation |
| Whole plant | Lumbago, indigestion, post-delivery tonic, fever, jaundice, cachexia, dropsy | Various decoctions |
III. Phytochemical Profile: Six Classes of Bioactive Compounds
The roots of E. longifolia are the richest source of bioactive compounds. Kuo et al. reported the isolation of 65 phenolic compounds from the root alone. The chemistry of the plant spans six major compound classes, with quassinoids constituting the dominant fraction and driving most of the studied pharmacological effects.
| Compound Class | Key Compounds | Primary Biological Role |
|---|---|---|
| Quassinoids (nortriterpenoids) | Eurycomanone (pasakbumin-A), eurycomalactone, eurycomanols, longilactones, laurycolactones, hydroxyklaineanones | Testosterone support, antimalarial, anticancer, anti-inflammatory, NF-κB inhibition |
| Canthin-6-one alkaloids | 9-methoxycanthin-6-one, 9-hydroxycanthin-6-one, 5,9-dimethoxycanthin-6-one | Cytotoxic (anticancer), antimicrobial, herbivore repellent |
| β-Carboline alkaloids | β-carboline-1-propionic acid, n-pentyl β-carboline-1-propionate, 1-hydroxy-9-methoxycanthin-6-one | Anti-inflammatory (Nrf2/HO-1 pathway), insect repellent |
| Tirucallane-type triterpenes | Tirucallane steroids | Possible quassinoid biosynthetic precursors |
| Squalene derivatives | Eurylene, teurilene, 14-deacetyleurylene, longilene peroxide | Cytotoxic activity |
| Biphenyl neolignans & lactones | Eurycolactone, laurycolactone, eurycomalactone, biphenyl ether dimers | Bioactive steroids; structural diversity |
IV. Evidence-Based Pharmacology
Aphrodisiac and Testosterone-Enhancing Effects
The aphrodisiac reputation of Tongkat Ali is the most extensively studied aspect of its pharmacology. Animal studies have demonstrated increased sexual motivation, improved spermatogenesis, elevated testosterone production via Leydig cell activation, and enhanced muscle mass. Human clinical trials confirm significant increases in serum testosterone in men with late-onset hypogonadism, and improvements in erectile function and libido scores. Eurycomanone and eurypeptides (bioactive polypeptides) are identified as the primary drivers, acting through stimulation of DHEA, reduction of SHBG, and enhancement of androgen biosynthesis.
Antimalarial Activity
Quassinoids, particularly eurycomanone and 13α(21)-epoxyeurycomanone, are the principal antimalarial constituents. In a field study in Mae Sot, Thailand, a standardized extract containing three major quassinoids was compared against artemisinin on 38 fresh Plasmodium falciparum isolates. The IC₅₀ of the extract was 14.72 μg/L, against artemisinin's 4.30 μg/L. Importantly, synergism between quassinoids — or the presence of unidentified compounds — produced antimalarial activity beyond that expected from the isolated compounds alone.
Cytotoxic and Anticancer Effects
| Cancer Cell Line / Type | Active Compound(s) | Mechanism |
|---|---|---|
| Human lung cancer (A-549) | Canthin-6-one, 9-methoxycanthin-6-one, longilactone, eurycomanone | Direct cytotoxicity; apoptosis induction |
| Human breast cancer (MCF-7) | Eurycomanone, eurycomalactone, pasakbumin B | Apoptosis via Bcl-2 reduction; intrinsic pathway |
| Cervical cancer (HeLa) | Eurycomanone, eurycomalactone, longilactone | Cell viability reduction to 21–67% at 100 μM |
| Prostate cancer (LNCaP) | Quassinoid mixture (SQ40) | G0/G1 cell cycle arrest; CDK4/CDK2 downregulation; p21 upregulation |
| Leukemia (K-562, CML) | TAF273 fraction; eurycomanone; eurycomanol | Apoptosis (caspase-9 independent); NF-κB inhibition via IκBα/MAPK |
| Acute promyelocytic leukemia (HL-60) | Fractions F2, F3 | IC₅₀ 15.2–28.6 μg/mL; growth inhibition |
Anti-Inflammatory Activity
The β-carboline alkaloid 7-MCPA (7-methoxy-(9H-β-carbolin-1-yl)-(E)-1-propenoic acid), isolated from hairy-root cultures, activates the Nrf2/HO-1 pathway via ROS-dependent p38 MAPK signaling. Among quassinoids, eurycomalactone, 14,15β-dihydroklaieanone, and 13,21-dehydroeurycomanone demonstrated potent NF-κB inhibition with IC₅₀ values below 1 μM — placing them among the more potent plant-derived NF-κB inhibitors documented.
Anxiolytic (Anti-Anxiety) Effect
In mouse behavioral tests — including the open field test, elevated plus-maze, and anti-fighting test — E. longifolia fractions produced anxiolytic effects comparable to diazepam (Valium). A human study with 63 subjects supplemented for 4 weeks found that daily hot-water extract reduced cortisol exposure by 16% and increased testosterone levels by 37%, alongside significant improvements in perceived tension, anger, and confusion.
Antidiabetic Effect
In streptozotocin-induced hyperglycaemic rats, aqueous extracts at 150 mg/kg body weight reduced blood glucose by 38–47% (p < 0.05 to p < 0.001). Root extract at 50 μg/mL increased insulin sensitivity by enhancing glucose uptake more than 200% and suppressed lipid accumulation in a concentration-dependent manner in 3T3-L1 adipocytes.
Osteoporosis Prevention
E. longifolia prevents androgen-deficient bone loss through multiple mechanisms: testosterone elevation via Leydig cell activation, stimulation of osteoblast proliferation and differentiation, pro-apoptotic effects on osteoclasts, antioxidant activity (superoxide dismutase content), and nitric oxide generation. In orchidectomised rat models, supplementation maintained bone calcium levels and upregulated OPG (osteoprotegerin) gene expression.
Antimicrobial Activity
Alcoholic and acetone leaf and stem extracts show activity against both Gram-positive (Staphylococcus aureus) and Gram-negative bacteria (Escherichia coli, Salmonella typhi, Pseudomonas aeruginosa), with inhibition zone diameters of 7–25 mm. Root extracts from multiple solvent fractions demonstrated cytotoxicity against KB, DU-145, RD, MCF-7, CaOV-3, and other human cancer cell lines, with 9-methoxycanthin-6-one identified as a key alkaloid contributor.
V. Pharmacology Summary Table
| Pharmacological Effect | Evidence Level | Primary Active Compound(s) | Key Finding |
|---|---|---|---|
| Testosterone enhancement / Aphrodisiac | Animal + Human RCTs | Eurycomanone, eurypeptides | Significant T increase; improved libido and sexual function |
| Antimalarial | In vitro + Animal + Field study | Eurycomanone, 13α(21)-epoxyeurycomanone | IC₅₀ 14.72 μg/L vs. P. falciparum; synergistic quassinoid activity |
| Anticancer / Cytotoxic | In vitro + Animal xenograft | Multiple quassinoids, canthin-6-one alkaloids | Active against lung, breast, cervical, prostate, leukemia cell lines |
| Anti-inflammatory | In vitro | 7-MCPA, eurycomalactone (IC₅₀ <1 μM NF-κB) | Nrf2/HO-1 activation; NF-κB inhibition |
| Anxiolytic | Animal + Human (RCT) | Hot-water root extract | Cortisol −16%; testosterone +37%; improved mood parameters |
| Antidiabetic | Animal + In vitro | Aqueous root extract | Blood glucose −38–47% in hyperglycaemic rats; glucose uptake +200% in vitro |
| Anti-osteoporotic | Animal models | Androgenic fractions, eurypeptides | Bone calcium preservation; OPG gene upregulation in orchidectomised rats |
| Antimicrobial | In vitro | 9-methoxycanthin-6-one; leaf/stem extracts | Active vs. S. aureus, P. aeruginosa, E. coli, S. typhi |
| Ergogenic (muscle, endurance) | Human studies (limited) | Androgenic fractions | Increased lean body mass and muscle strength; anecdotal reports supported by T data |
VI. Evidence-Based Toxicology and Safety
LD50 and Acute Toxicity Data
| Extract Type | Oral LD50 (Mice) | Safe Daily Dose (Animal Data) | Human ADI Estimate |
|---|---|---|---|
| Alcoholic extract | 1,500–2,000 mg/kg | 200 mg/kg (ethanolic); hepatotoxic effects only above 1,200 mg/kg | — |
| Aqueous extract | >3,000 mg/kg | 300 mg/kg (aqueous) showed no toxicity | Up to 1.2 g/adult/day (Li et al.) |
| Standardized aqueous | Male >2,000 mg/kg; Female 1,293 mg/kg | No adverse changes at 250–2,000 mg/kg over 90 days | 400 mg/day (human trial; non-toxic to liver/kidney) |
| n-Butanol fraction | Most toxic fraction (eurycomanone-driven) | Lower than aqueous; requires caution | Not recommended without standardization |
Precautions and Contraindications
Use with caution in patients on hypoglycaemic agents (blood glucose interaction documented in animals) and propranolol (decreased bioavailability shown in healthy males). Avoid in individuals with prostate cancer, breast cancer, heart disease, kidney disease, liver disease, sleep apnea, or known hypersensitivity to the Simaroubaceae family. Not recommended during pregnancy, lactation, or in children due to insufficient safety data.
Technical Glossary
Frequently Asked Questions
What is Tongkat Ali used for traditionally?
Traditional uses vary by plant part. The roots and root bark are used for sexual dysfunction, fever, malaria, diabetes, and high blood pressure. The leaves are used in topical washes for skin itches. The bark serves as a vermifuge, and the fruits treat dysentery. Whole-plant preparations address lumbago, jaundice, and post-delivery recovery.
What are the main bioactive compounds in Tongkat Ali?
Six compound classes are identified: quassinoids (the most abundant, including eurycomanone), canthin-6-one alkaloids, β-carboline alkaloids, tirucallane-type triterpenes, squalene derivatives (including eurylene), and biphenyl neolignans/lactones. Eurycomanone is the most pharmacologically studied single compound.
What cancers has Tongkat Ali been tested against?
In vitro and animal studies have demonstrated cytotoxic activity against human lung cancer (A-549), breast cancer (MCF-7), cervical cancer (HeLa), prostate cancer (LNCaP), chronic myelogenous leukemia (K-562), acute promyelocytic leukemia (HL-60), and nasopharyngeal carcinoma (KB) cell lines. Clinical trials in humans have not yet been conducted.
Is Tongkat Ali safe at normal doses?
Yes, at the recommended dose of 200–400 mg/day, liver and kidney function tests show no adverse changes. The oral LD50 of the aqueous extract exceeds 3,000 mg/kg in mice, and a 90-day subchronic toxicity study in rats found no significant changes in blood chemistry, histopathology, or behavior at doses up to 2,000 mg/kg/day.
How does Tongkat Ali compare across extract types?
The water-based fraction is the safest, with the highest LD50 (>3,000 mg/kg) and the best-documented human safety profile. Alcoholic extracts have lower LD50 values (1,500–2,000 mg/kg). The n-butanol fraction is the most toxic due to high eurycomanone concentration. Extract type and standardization are therefore critical variables in both safety and efficacy.
What are the common names of Eurycoma longifolia?
Tongkat Ali and Malaysian Ginseng (Malaysia), Pasak Bumi and Bedara Pahit (Indonesia), Ian-don (Thailand), Cay ba benh (Vietnam), and Tho nan (Laos). The name "Tongkat Ali" translates to "Ali's walking stick," a reference to its long twisted roots and its traditional reputation as an aphrodisiac.